CARs versus BiTEs: A Comparison between T Cell-Redirection Strategies for Cancer Treatment

Cancer Discovery
Clare Y SlaneyMichael H Kershaw

Abstract

The redirection of T cells against tumors holds much promise for the treatment of cancer. Two main approaches for T-cell redirection involve their genetic modification with chimeric antigen receptors (CAR), or the use of recombinant proteins designated bispecific T-cell engagers (BiTE). These approaches have demonstrated dramatic effects in patients with hematologic cancers, although limited effect against solid cancers. Here, we review and compare the successes and challenges of these two types of immunotherapies, with special focus on their mechanisms, and discuss strategies to improve their efficacy against cancer.Significance: CAR and BiTE cancer therapies have generated much excitement, but although the therapies are potentially competitive, information directly comparing the two is difficult to obtain. Here, we present the fundamentals of each approach and compare the range and level of functions they can elicit from T cells, and their efficacy against cancers. Cancer Discov; 8(8); 924-34. ©2018 AACR.

References

Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Patrick HoffmannPatrick A Baeuerle
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael H KershawPatrick Hwu
Sep 15, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Renier J BrentjensMichel Sadelain
Jan 23, 2009·Immunobiology·Cornelia HaasPatrick A Baeuerle
May 26, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edmund K MoonSteven M Albelda
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Dec 1, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Evripidis LanitisDaniel J Powell
Feb 1, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dhanalakshmi ChinnasamySteven A Rosenberg
May 16, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul SpearCharles L Sentman
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
Apr 4, 2013·Cancer Discovery·Michel SadelainIsabelle Rivière
Jun 5, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sunitha KakarlaStephen Gottschalk
Jul 9, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·David S RitchieH Miles Prince
Jul 23, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liza B JohnPhillip K Darcy
Jul 25, 2013·Nature Reviews. Cancer·Michael H KershawPhillip K Darcy
Apr 16, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ann M LeenJuan F Vera
Jun 13, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edmund K MoonSteven M Albelda
Aug 22, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kota IwahoriStephen Gottschalk
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Dec 6, 2014·Cancer Research·Clare Y SlaneyPhillip K Darcy
Feb 1, 2015·Molecular Immunology·Christoph SpiessPaul J Carter
Feb 26, 2015·Cancer Immunology Research·Alexander J DavenportPaul J Neeson
Mar 25, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nabil AhmedStephen Gottschalk

❮ Previous
Next ❯

Citations

Jan 18, 2020·International Journal of Molecular Sciences·Rebecca C AbbottMisty R Jenkins
Apr 25, 2020·Angewandte Chemie·Junpeng QiHaiyong Peng
Sep 24, 2019·Antibodies·Qiong WangMichael J Betenbaugh
Feb 15, 2020·Nature Reviews. Clinical Oncology·Wade T IamsLeora Horn
Mar 29, 2020·Nature Reviews. Cardiology·Joerg Herrmann
Jun 27, 2020·Toxicological Sciences : an Official Journal of the Society of Toxicology·Christine KarbowskiHerve Lebrec
Jun 18, 2019·Therapeutic Advances in Hematology·Veronica A GuerraNicholas J Short
Feb 28, 2019·Frontiers in Oncology·Aesha I AliClare Y Slaney
Jun 26, 2020·Cancers·Kambiz AfrasiabiYi-Hong Zhou
Apr 4, 2020·Nature Reviews. Clinical Oncology·Maria-Elisabeth Goebeler, Ralf C Bargou
Apr 2, 2020·Nature Reviews. Cardiology·Joerg Herrmann
Aug 23, 2020·Cancers·Leonardo ChicaybamBryan E Strauss
Sep 4, 2020·International Journal of Molecular Sciences·Annamaria SandomenicoMenotti Ruvo
Oct 9, 2020·International Journal of Molecular Sciences·Fiona A Desland, Adília Hormigo
Nov 11, 2020·International Journal of Molecular Sciences·Negar HosseinkhaniBehzad Baradaran
Nov 2, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adam D CohenMadhav V Dhodapkar
Nov 2, 2018·Molecular Cancer Therapeutics·Hreinn BenonissonThorbald van Hall
Feb 6, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Giovanni FucàGianpietro Dotti
Oct 10, 2020·Annual Review of Pharmacology and Toxicology·Edward Z Song, Michael C Milone
Jan 16, 2020·Immunity·Jackson G EgenLawren C Wu
Jan 27, 2021·Blood Advances·John C Molina, Nirali N Shah
Jan 24, 2021·Experimental Hematology·Norman F RusskampMarkus G Manz
Sep 22, 2020·Panminerva Medica·Yunxin ChenClaudio Cerchione
Feb 11, 2021·Personalized Medicine·Alicja ZalewskiScott A Waldman
Nov 18, 2020·Biomedicines·Dragoș-Mihai RomitanTudor-Eliade Ciuleanu
Nov 1, 2020·Cancers·Clare Y Slaney, Michael H Kershaw
Dec 10, 2020·Experimental Hematology & Oncology·Le Li, Ying Wang
Dec 17, 2019·Current Opinion in Biotechnology·Christoph Rader
Jan 21, 2021·Cancers·Jim MiddelburgThorbald van Hall
Feb 13, 2021·Nature Medicine·Ilio VitaleLorenzo Galluzzi
Feb 17, 2021·Nature Protocols·Stefan KiesgenPrasad S Adusumilli
Feb 3, 2021·Cancers·Vincenzo Maria PerrielloLorenzo Brunetti
Mar 5, 2021·Molecular Cancer·Lien Van HoeckeSandra Van Lint

❮ Previous
Next ❯

Related Concepts

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nicole C Smits, Charles L Sentman
Immunological Reviews
Michelle H Nelson, Chrystal M Paulos
Translational Research : the Journal of Laboratory and Clinical Medicine
David Chen, James Yang
© 2022 Meta ULC. All rights reserved